Are Antiresorptive Drugs Effective Against Fractures in Patients with Diabetes?
- 16 December 2010
- journal article
- research article
- Published by Springer Nature in Calcified Tissue International
- Vol. 88 (3) , 209-214
Abstract
We studied whether the reduction in bone turnover by use of antiresorptive drugs is detrimental in patients with diabetes who already have low bone turnover due to hyperglycemia in a nationwide cohort study from Denmark. All users of antiresorptive drugs against osteoporosis between 1996 and 2006 (n = 103,562) were the exposed group, with three age- and gender-matched controls from the general population (n = 310,683). Patients on bisphosphonates and raloxifene had a higher risk of hip, spine, and forearm fractures. However, no difference was observed in the antifracture efficacy between patients with diabetes and nondiabetic controls or between patients with type 1 and type 2 diabetes. Too few were users of strontium to allow analysis for this compound. The excess risk of fractures among patients treated with bisphosphonates or raloxifene compared to nonexposed controls was due to the higher a priori risk of fractures among patients treated for osteoporosis. Diabetes does not seem to affect the fracture-preventive potential of bisphosphonates or raloxifene. The low-turnover state of diabetes thus does not seem to be a hindrance to the effect of these drugs against osteoporosis. Therefore, patients with diabetes should receive treatment for osteoporosis in the same way as nondiabetic patients.Keywords
This publication has 25 references indexed in Scilit:
- Plasma Osteocalcin Is Inversely Related to Fat Mass and Plasma Glucose in Elderly Swedish MenJournal of Bone and Mineral Research, 2009
- Rosiglitazone Decreases Serum Bone-Specific Alkaline Phosphatase Activity in Postmenopausal Diabetic WomenThe Journal of Clinical Endocrinology & Metabolism, 2007
- Endocrine Regulation of Energy Metabolism by the SkeletonCell, 2007
- Systematic Review of Type 1 and Type 2 Diabetes Mellitus and Risk of FractureAmerican Journal of Epidemiology, 2007
- Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysisOsteoporosis International, 2006
- Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitusOsteoporosis International, 2005
- Bone metabolism in male patients with type 2 diabetesClinical Rheumatology, 2005
- Improving Metabolic Control Reverses the Histomorphometric and Biomechanical Abnormalities of an Experimentally Induced Bone Defect in Spontaneously Diabetic RatsCalcified Tissue International, 2004
- Octreotide Abolishes the Acute Decrease in Bone Turnover in Response to Oral GlucoseThe Journal of Clinical Endocrinology & Metabolism, 2003
- Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurementsGynecological Endocrinology, 2003